{{Rsnum
|rsid=4802207
|Gene=ZNF224
|Chromosome=19
|position=44096224
|Orientation=plus
|GMAF=0.4284
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ZNF224
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 2.7 | 31.2 | 66.1
| HCB | 23.5 | 50.0 | 26.5
| JPT | 21.6 | 47.7 | 30.6
| YRI | 58.3 | 37.5 | 4.2
| ASW | 49.1 | 36.8 | 14.0
| CHB | 23.5 | 50.0 | 26.5
| CHD | 15.6 | 60.6 | 23.9
| GIH | 8.9 | 34.7 | 56.4
| LWK | 56.9 | 31.2 | 11.9
| MEX | 29.3 | 36.2 | 34.5
| MKK | 42.2 | 47.4 | 10.4
| TSI | 5.9 | 25.7 | 68.3
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs4802207
|Name_s=
|Gene_s=ZNF224
|Feature=
|Evidence=PubMed ID:19118814
|Annotation=This variant is significantly associated with late-onset Alzheimer disease (LOAD) in a GWAS study with 492 LOAD cases and 498 cognitive controls using Illumina's HumanHap550 beadchip.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363835
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs4802207
|overall_frequency_n=68
|overall_frequency_d=118
|overall_frequency=0.576271
|n_genomes=36
|n_genomes_annotated=0
|n_haplomes=55
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}